Literature DB >> 3170779

Nosocomial outbreak of Achromobacter xylosoxidans associated with a diagnostic contrast solution.

J Reina, M Antich, B Siquier, P Alomar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3170779      PMCID: PMC1141632          DOI: 10.1136/jcp.41.8.920-c

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  3 in total

1.  Achromobacter xylosoxidans n. sp. from human ear discharge.

Authors:  E Yabuuchi; A Oyama
Journal:  Jpn J Microbiol       Date:  1971-09

2.  Nosocomial colonization and infection by Achromobacter xylosoxidans.

Authors:  M E Reverdy; J Freney; J Fleurette; M Coulet; M Surgot; D Marmet; C Ploton
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

3.  Clinical and laboratory characteristics of Achromobacter xylosoxidans infection.

Authors:  Y Igra-Siegman; H Chmel; C Cobbs
Journal:  J Clin Microbiol       Date:  1980-02       Impact factor: 5.948

  3 in total
  11 in total

1.  Bacteremia due to glucose non-fermenting gram-negative bacilli in patients with hematological neoplasias and solid tumors.

Authors:  R Martino; C Martínez; R Pericas; R Salazar; C Solá; S Brunet; A Sureda; A Domingo-Albós
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-07       Impact factor: 3.267

2.  Identification of a carbenicillin-hydrolyzing beta-lactamase in Alcaligenes denitrificans subsp. xylosoxydans.

Authors:  D Decré; G Arlet; E Bergogne-Bérézin; A Philippon
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

3.  Investigation of hospital-acquired infections due to Alcaligenes denitrificans subsp. xylosoxydans by DNA restriction fragment length polymorphism.

Authors:  M Cheron; E Abachin; E Guerot; M el-Bez; M Simonet
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

4.  Outbreak of long-term intravascular catheter-related bacteremia due to Achromobacter xylosoxidans subspecies xylosoxidans in a hemodialysis unit.

Authors:  D Tena; R Carranza; J R Barberá; S Valdezate; J M Garrancho; M Arranz; J A Sáez-Nieto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-11       Impact factor: 3.267

5.  Achromobacter xylosoxidans infection presenting as a pulmonary nodule mimicking cancer.

Authors:  Stephanie L Claassen; Jason M Reese; Vincent Mysliwiec; Steven D Mahlen
Journal:  J Clin Microbiol       Date:  2011-05-18       Impact factor: 5.948

6.  Achromobacter spp. bacteremia outbreak related to contaminated furosemide ampoules.

Authors:  Rajalakshmi Arjun; Kalpana E John; Vettakkara Kandy Muhammed Niyas; Sreerekha R Nair; Viji Mohan; Raveendran Sarala Ratheesh
Journal:  Infez Med       Date:  2021-09-10

7.  Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases.

Authors:  J Gómez-Cerezo; I Suárez; J J Ríos; P Peña; M J García de Miguel; M de José; O Monteagudo; P Linares; A Barbado-Cano; J J Vázquez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-05-16       Impact factor: 3.267

8.  Achromobacter species endocarditis: A case report and literature review.

Authors:  Catherine Derber; Kara Elam; Betty A Forbes; Gonzalo Bearman
Journal:  Can J Infect Dis Med Microbiol       Date:  2011       Impact factor: 2.471

9.  Outbreak of Achromobacter xylosoxidans and Ochrobactrum anthropi Infections after Prostate Biopsies, France, 2014.

Authors:  Skerdi Haviari; Pierre Cassier; Cédric Dananché; Monique Hulin; Olivier Dauwalder; Olivier Rouvière; Xavier Bertrand; Michel Perraud; Thomas Bénet; Philippe Vanhems
Journal:  Emerg Infect Dis       Date:  2016-08       Impact factor: 6.883

10.  Isolation and characterization of numerous novel phages targeting diverse strains of the ubiquitous and opportunistic pathogen Achromobacter xylosoxidans.

Authors:  Johannes Wittmann; Brigitte Dreiseikelmann; Christine Rohde; Manfred Rohde; Johannes Sikorski
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.